VZ
27
3
BMY
43
-3
VTR
35
4
NOC
45
2
XEL
51
8
FSLR
57
-4
UA
51
-5
CNP
47
6
MS
69
3
ROST
61
5
CNX
49
7
STI
10
-13
LLY
37
4
AON
36
4
CSCO
67
3
SYK
50
8
DIS
73
-2
PCG
58
-8
NWL
49
-3
PBI
35
2
VZ
27
3
BMY
43
-3
VTR
35
4
NOC
45
2
XEL
51
8
FSLR
57
-4
UA
51
-5
CNP
47
6
MS
69
3
ROST
61
5
CNX
49
7
STI
10
-13
LLY
37
4
AON
36
4
CSCO
67
3
SYK
50
8
DIS
73
-2
PCG
58
-8
NWL
49
-3
PBI
35
2
Financhill
Back

General Mills Vs. Janux Therapeutics Industry Stock Comparison

Sell
34

GIS
General Mills

Last Price:
$60.97
Seasonality Move:
1.84%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
34
General Mills (GIS) is a Sell

Is General Mills a Buy, Sell or Hold?

  • The current General Mills [GIS] share price is $60.97. The Score for GIS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • GIS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GIS Stock Price Chart

What is General Mills's stock price today?

  • The General Mills share price today is $60.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

GIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.08 Sell
Relative Strength Index (14 RSI): 29.21 Sell
Chaikin Money Flow: 5158300 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.77 - 65.91) Sell
Bollinger Bands (100): (64.56 - 72.7) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

GIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.73 Sell
20-day SMA: 64.02 Sell
50-day SMA: 65.06 Sell
200-day SMA: 68.2 Sell
8-day EMA: 62.38 Sell
20-day EMA: 63.57 Sell
50-day EMA: 65.29 Sell
200-day EMA: 67.65 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

General Mills Earnings Growth & GIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.30 per share, a decrease this year of $0.09 per share, and an increase next year of $0.17 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

General Mills Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):